Reprogramming of a melanoma genome by nuclear transplantation

Genes and Development

Volumn 18, Issue 15, 2004, Pages 1875-1885

  Hochedlinger, Konrad ^a   Blelloch, Robert ^a,b   Brennan, Cameron ^c   Yamada, Yasuhiro ^a   Kim, Minjung ^c   Chin, Lynda ^c   Jaenisch, Rudolf ^a  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cancer; Embryonic stem cells; Epigenetics; Nuclear transfer; Pluripotency; Reprogramming

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLASTOCYST; CANCER CELL; CELL DIFFERENTIATION; CELL NUCLEUS; CELL NUCLEUS TRANSPLANTATION; CHIMERA; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FIBROBLAST; FLUORESCENCE ACTIVATED CELL SORTING; GENOME; LYMPHOCYTE; MELANOCYTE; MELANOMA; MOUSE; NONHUMAN; PENETRANCE; PRIORITY JOURNAL; TERATOMA;

ANIMALS; BLASTOCYST; BREAST NEOPLASMS; CELL DIFFERENTIATION; CHIMERA; DNA-BINDING PROTEINS; EMBRYO; FIBROBLASTS; GENES, RAS; GENOME; LEUKEMIA; LYMPHOCYTES; LYMPHOMA; MELANOCYTES; MELANOMA; MICE; MICE, INBRED C57BL; MICE, SCID; NUCLEAR TRANSFER TECHNIQUES; OOCYTES; STEM CELLS; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 3543073392     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.1213504     Document Type: Article

References (52)

1. Al-Hajj, M., Becker, M.W., Wicha, M., Weissman, I., and Clarke, M.F. 2004. Therapeutic implications of cancer stem cells. Curr. Opin. Genet. Dev. 14: 43-47.
2. Bachoo, R.M., Maher, E.A., Ligon, K.L., Sharpless, N.E., Chan, S.S., You, M.J., Tang, Y., DeFrances, J., Stover, E., Weissleder, R., et al. 2002. Epidermal growth factor receptor and Ink4a/Arf: Convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis, Cancer Cell 1: 269-277.
3. Bakin, A.V. and Curran, T. 1999. Role of DNA 5-methylcytosine transferase in cell transformation by fos. Science 283: 387-390.
4. Brennan, C., Zhang, Y., Leo, C., Feng, B., Cauwles, C., Aguirre, A.J., Kim, M., Protopopov, A., and Chin, L. 2004. High-resolution global profiling of genomic alterations with long oligonucleotide microarray. Cancer Res. (in press).
5. Bridge, J.A., Liu, J., Qualman, S.J., Suijkerbuijk, R., Wenger, G., Zhang, J., Wan, X., Baker, K.S., Sorensen, P., and Barr, F.G. 2002. Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes. Genes Chromosomes Cancer 33: 310-321.
6. Carlson, D.L., Sauerbier, W., Rollins-Smith, L.A., and McKinnell, R.G. 1994. Fate of herpesvirus DNA in embryos and tadpoles cloned from Lucké renal carcinoma nuclei. J. Comp. Pathol. 111: 197-203.
7. Chang, S., Khoo, C.M., Naylor, M.L., Maser, R.S., and DePinho, R.A. 2003. Telomere-based crisis: Functional differences between telomerase activation and ALT in tumor progression. Genes & Dev. 17: 88-100.
8. Chen, J., Lansford, R., Stewart, V., Young, F., and Alt, F.W. 1993. RAG-2-deficient blastocyst complementation: an assay of gene function in lymphocyte development. Proc. Natl. Acad. Sci. 90: 4528-4532.
9. Chin, L. 2003. The genetics of malignant melanoma: Lessons from mouse and man. Nat. Rev. Cancer 3: 559-570.
10. Chin, L., Tam, A., Pomerantz, J., Wong, M., Holash, J., Bardeesy, N., Shen, Q., O'Hagan, R., Pantginis, J., Zhou, H., et al. 1999. Essential role for oncogenic Ras in tumour maintenance. Nature 400: 468-472.
11. Di Croce, L., Raker, V.A., Corsaro, M., Fazi, F., Fanelli, M., Faretta, M., Fuks, F., Lo Coco, F., Kouzarides, T., Nervi, C., et al. 2002. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science 295: 1079-1082.
12. Donehower, L.A., Harvey, M., Slagle, B.L., McArthur, M.J., Montgomery Jr., C.A., Butel, J.S., and Bradley, A. 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215-221.
13. Eggan, K., Akutsu, H., Loring, J., Jackson-Grusby, L., Klemm, M., Rideout III, W.M., Yanagimachi, R., and Jaenisch, R. 2001. Hybrid vigor, fetal overgrowth, and viability of mice derived by nuclear cloning and tetraploid embryo complementation. Proc. Natl. Acad. Sci. 98: 6209-6214.
14. Eggan, K., Rode, A., Jentsch, I., Samuel, C., Hennek, T., Tintrup, H., Zevnik, B., Erwin, J., Loring, J., Jackson-Grusby, L., et al. 2002. Male and female mice derived from the same embryonic stem cell clone by tetraploid embryo complementation. Nat. Biotechnol. 20: 455-459.
15. Eggan, K., Baldwin, K., Tackett, M., Osborne, J., Gogos, J., Chess, A., Axel, R., and Jaenisch, R. 2004. Mice cloned from olfactory sensory neurons. Nature 428: 44-49. Epub 2004 Feb 15; doi: 10.1038/nature02375.
16. Egger, G., Liang, G., Aparicio, A., and Jones, P.A. 2004. Epigenetics in human disease and prospects for epigenetic therapy. Nature 429: 457-463.
17. Felsher, D.W. 2003. Cancer revoked: Oncogenes as therapeutic targets. Nat. Rev. Cancer 3: 375-380.
18. Frank, S.R., Parisi, T., Taubert, S., Fernandez, P., Fuchs, M., Chan, H.M., Livingston, D.M., and Amati, B. 2003. MYC recruits the TIP60 histone acetyltransferase complex to chromatin. EMBO Rep. 4: 575-580.
19. Gaudet, F., Hodgson, J.G., Eden, A., Jackson-Grusby, L., Dausman, J., Gray, J.W., Leonhardt, H., and Jaenisch, R. 2003. Induction of tumors in mice by genomic hypomethylation. Science 300: 489-492.
20. Hahn, W.C. and Weinberg, R.A. 2002. Rules for making human tumor cells, N. Engl. J. Med. 347: 1593-1603.
21. Hochedlinger, K. and Jaenisch, R. 2002a. Monoclonal mice generated by nuclear transfer from mature B and T donor cells. Nature 415: 1035-1038.
22. -. 2002b. Nuclear transplantation: Lessons from frogs and mice. Curr. Opin. Cell Biol. 14: 741-748.
23. -. 2003. Nuclear transplantation, embryonic stem cells, and the potential for cell therapy. N. Engl. J. Med. 349: 275-286.
24. Hwang, W.S., Ryu, Y.J., Park, J.H., Park, E.S., Lee, E.G., Koo, J.M., Chun, H.Y., Lee, B.C., Kang, S.K., Kim, S.J., et al. 2004. Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocyst. Science 303: 1669-1674.
25. Jaenisch, R., Jahner, D., Nobis, P., Simon, I., Lohler, J., Harbers, K., and Grotkopp, D. 1981. Chromosomal position and activation of retroviral genomes inserted into the germ line of mice. Cell 24: 519-529.
26. Jain, M., Arvanitis, C., Chu, K., Dewey, W., Leonhardt, E., Trinh, M., Sundberg, C.D., Bishop, J.M., and Felsher, D.W. 2002. Sustained loss of a neoplastic phenotype by brief inactivation of MYC. Science 297: 102-104.
27. Jones, P.A. and Baylin, S.B. 2002. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3: 415-428.
28. Katsuki, M., Kimura, M., Hata, J., Takahashi, R., Nozawa, S., Yokoyama, M., Izawa, M., Sekiya, T., Nishimura, S., and Nomura, T. 1989. Embryonal tumors from transgenic mouse zygotes carrying human activated c-Ha-ras genes. Mol. Biol. Med. 6: 567-572.
29. Kuperwasser, C., Hurlbut, G.D., Kittrell, F.S., Dickinson, E.S., Laucirica, R., Medina, D., Naber, S.P., and Jerry, D.J. 2000. Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice. A model for Li-Fraumeni syndrome. Am. J. Pathol. 157: 2151-2159.
30. Li, E. 2002. Chromatin modification and epigenetic reprogramming in mammalian development. Nat. Rev. Genet. 3: 662-673.
31. Li, L., Connelly, M.C., Wetmore, C., Curran, T., and Morgan, J.I. 2003. Mouse embryos cloned from brain tumors. Cancer Res. 63: 2733-2736.
32. Liu, X., Wu, H., Loring, J., Hormuzdi, S., Disteche, C.M., Bornstein, P., and Jaenisch, R. 1997. Trisomy eight in ES cells is a common potential problem in gene targeting and interferes with germ line transmission. Dev. Dyn. 209: 85-91.
33. Lucito, R., Healy, J., Alexander, J., Reiner, A., Esposito, D., Chi, M., Rodgers, L., Brady, A., Sebat, J., Troge, J., et al. 2003. Representational oligonucleotide microarray analysis: A high-resolution method to detect genome copy number variation. Genome Res. 13: 2291-2305.
34. Ludes-Meyers, J.H., Bednarek, A.K., Popescu, N.C., Bedford, M., and Aldaz, C.M. 2003. WWOX, the common chromosomal fragile site, FRA16D, cancer gene. Cytogenet. Genome Res. 100: 101-110.
35. McKinnell, R.G., Deggins, B.A., and Labat, D.D. 1969. Transplantation of pluripotential nuclei from triploid frog tumors. Science 165: 394-396.
36. Ogawa, H., Ishiguro, K., Gaubatz, S., Livingston, D.M., and Nakatani, Y. 2002. A complex with chromatin modifiers that occupies E2F- and Myc-responsive genes in G0 cells. Science 296: 1132-1136.
37. Olshen, A. and Venkatraman, E. 2004. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics (in press).
38. Pardal, R., Clarke, M.F., and Morrison, S.J. 2003. Applying the principles of stem-cell biology to cancer. Nat. Rev. Cancer 3: 895-902.
39. Peters, A.H., O'Carroll, D., Scherthan, H., Mechtler, K., Sauer, S., Schofer, C., Weipoltshammer, K., Pagani, M., Lachner, M., Kohlmaier, A., et al. 2001. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 107: 323-337.
40. Pollack, J.R., Perou, C.M., Alizadeh, A.A., Eisen, M.B., Pergamenschikov, A., Williams, C.F., Jeffrey, S.S., Botstein, D., and Brown, P.O. 1999. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat. Genet. 23: 41-46.
41. Reya, T., Morrison, S.J., Clarke, M.F., and Weissman, I.L. 2001. Stem cells, cancer, and cancer stem cells. Nature 414: 105-111.
42. Rideout III, W.M., Eggan, K., and Jaenisch, R. 2001. Nuclear cloning and epigenetic reprogramming of the genome. Science 293: 1093-1098.
43. Rideout, W.M., Hochedlinger, K., Kyba, M., Daley, G.Q., and Jaenisch, R. 2002. Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell 109: 17-27.
44. Sanz, M.A., Martin, G., and Diaz-Mediavilla, J. 1998. All-transretinoic acid in acute promyelocytic leukemia. N. Engl. J. Med. 338: 393-394.
45. Sharp, R., Recio, J.A., Jhappan, C., Otsuka, T., Liu, S., Yu, Y., Liu, W., Anver, M., Navid, F., Helman, L.J., et al. 2002. Synergism between INK4a/ARF inactivation and aberrant HGF/ SF signaling in rhabdomyosarcomagenesis. Nat. Med. 8: 1276-1280.
46. Stewart, C., Harbers, K., Jahner, D., and Jaenisch, R. 1983. X chromosome-linked transmission and expression of retroviral genomes microinjected into mouse zygotes. Science 221: 760-762.
47. Visser, M., Sijmons, C., Bras, J., Arceci, R.J., Godfried, M., Valentijn, L.J., Voute, P.A., and Baas, F. 1997. Allelotype of pediatric rhabdomyosarcoma. Oncogene 15: 1309-1314.
48. Wakayama, T. and Yanagimachi, R. 2001. Mouse cloning with nucleus donor cells of different age and type. Mol. Reprod. Dev. 58: 376-383.
49. Wakayama, T., Perry, A.C., Zuccotti, M., Johnson, K.R., and Yanagimachi, R. 1998. Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei. Nature 394: 369-374.
50. Wang, Z.Q., Kiefer, F., Urbanek, P., and Wagner, E.F. 1997. Generation of completely embryonic stem cell-derived mutant mice using tetraploid blastocyst injection. Mech. Dev. 62: 137-145.
51. Wilmut, I., Schnieke, A.E., McWhir, J., Kind, A.J., and Campbell, K.H. 1997. Viable offspring derived from fetal and adult mammalian cells. Nature 385: 810-813.
52. Zimonjic, D.B., Pollock, J.L., Westervelt, P., Popescu, N.C., and Ley, T.J. 2000. Acquired, nonrandom chromosomal abnormalities associated with the development of acute promyelocytic leukemia in transgenic mice. Proc. Natl. Acad. Sci. 97: 13306-13311.